NOTCH2 and thyroid tumor: In this particular case, the molecular heterogeneity unveiled by MALDI–MSI can be at least in part explained by a possible acquisition of additional genetic events (e.g., NOTCH2 mutation), which have already been reported in other forms of thyroid tumours and are thought to worsen the biological aggressiveness of the tumour [25].